BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 190841)

  • 1. The effect of treatment of hyper- and hypothyroidism on urinary excretion of cyclic adenosine 3',5'-monophosphate.
    Carter DJ; Heath DA
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):542-7. PubMed ID: 190841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epinephrine-induced alterations in urinary cyclic AMP in hyper- and hypothyroidism.
    Guttler RB; Shaw JW; Otis CL; Nicologg JT
    J Clin Endocrinol Metab; 1975 Oct; 41(4):707-11. PubMed ID: 170297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary cyclic nucleotide levels in patients with hyper- and hypothyroidism.
    Tucci JR; Kopp L
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1323-9. PubMed ID: 187614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the usefulness of the plasma adenosine 3' 5' - cyclic monophosphate response to glucagon in thyroid disease.
    Mac Neil S; Hendy GN; Amirrasooli H; Daggett PR; Tomlinson S
    J Endocrinol Invest; 1980; 3(4):401-4. PubMed ID: 6259251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of carnitine in patients with hyperthyroidism and hypothyroidism: augmentation by thyroid hormone.
    Maebashi M; Kawamura N; Sato M; Imamura A; Yoshinaga K
    Metabolism; 1977 Apr; 26(4):351-6. PubMed ID: 846404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intact parathyroid hormone concentration and cyclic AMP metabolism in thyroid disease.
    Fraser WD; Logue FC; MacRitchie K; Wilson RM; Gray HW; Beastall GH; O'Reilly DS
    Acta Endocrinol (Copenh); 1991 Jun; 124(6):652-7. PubMed ID: 1648852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factors and the thyroid: effects of treatment for hyper- and hypothyroidism on serum IGF-I and urinary epidermal growth factor concentrations.
    Westermark K; Alm J; Skottner A; Karlsson A
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):415-21. PubMed ID: 3260708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and urine cyclic nucleotide levels in patients with hyperthyroidism and hypothyroidism.
    Peracchi M; Bamonti-Catena F; Lombardi L; Reschini E; Toschi V; Maiolo AT; Polli EE
    J Endocrinol Invest; 1983 Jun; 6(3):173-7. PubMed ID: 6311890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings. Urinary cyclic AMP excretion in thyroid disease.
    Carter DJ; Heath DA
    Clin Sci Mol Med; 1974 Nov; 47(5):19P-20P. PubMed ID: 4373200
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary cyclic AMP in hyperthyroidism.
    de Nutte N; Demeester-Mirkine N; Six R; Corvilain J; de Backer M
    Horm Metab Res; 1978 Jul; 10(4):315-8. PubMed ID: 210095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cyclic AMP response to glucagon as an index of tissue responsiveness to thyroid hormone.
    Paisey R; Elkeles RS; Hambley J; Belchetz PE
    Diabete Metab; 1978 Dec; 4(4):267-70. PubMed ID: 215472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid function and plasma cyclic AMP response to intravenous glucagon.
    Madsen SN
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):760-8. PubMed ID: 196468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine TRH immunoreactivity in hypothyroid and hyperthyroid patients.
    Suhonen AS; Leppäluoto J; Salmi J
    Acta Endocrinol (Copenh); 1984 Apr; 105(4):482-6. PubMed ID: 6426229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of propranolol and atenolol on plasma and urinary cyclic adenosine 3',5'-monophosphate in hyperthyroid patients.
    Nilsson OR; Andersson RG; Karlberg BE
    Acta Endocrinol (Copenh); 1980 May; 94(1):38-45. PubMed ID: 6247872
    [No Abstract]   [Full Text] [Related]  

  • 15. Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage.
    Beckett GJ; Kellett HA; Gow SM; Hussey AJ; Hayes JD; Toft AD
    Br Med J (Clin Res Ed); 1985 Aug; 291(6493):427-31. PubMed ID: 3926229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma adenosine 3':5'-cyclic monophosphate response to glucagon in thyroid disease.
    Elkeles RS; Lazarus JH; Siddle K; Campbell AK
    Clin Sci Mol Med; 1975 Jan; 48(1):27-31. PubMed ID: 163165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The calcium pump of cardiac sarcoplasmic reticulum. Functional alterations at different levels of thyroid state in rabbits.
    Suko J
    J Physiol; 1973 Feb; 228(3):563-82. PubMed ID: 4267211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory thresholds and motor responsiveness in thyroid disease: their responses to treatment and warming.
    O'Malley BP; Abbott RJ; Timson L; Beck AD; Rosenthal FD
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):17-23. PubMed ID: 4028463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between thyroid function and the renal response to parathyroid hormone.
    Ashby JP; MacPherson JN; Strong JA
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):167-70. PubMed ID: 196793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose and free fatty acid turnover in thyrotoxicosis and hypothyroidism, before and after treatment.
    Saunders J; Hall SE; Sönksen PH
    Clin Endocrinol (Oxf); 1980 Jul; 13(1):33-44. PubMed ID: 7438462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.